1. Temozolomide Oncology Drug Advisory Committee March 13, 2003 Craig L. Tendler, M.D. Vice President, Oncology Clinical Research 2. Agenda Basis for the accelerated approval…
1.Spike sor t ingTut or ial igo Quian Quir ogaRodr2. Problem: detect and separate spikescorresponding to different neurons 3. Goals:• Algorithm for automatic detection…
1. New Frontiers in Neuroendocrine Tumors TreatmentCarlos Frederico PintoInstituto de Oncologia do Vale Hospital Regional do Vale do Paraiba 2008 2. Neuroendocrine Tumors…
NEWER ANTIEPILEPTIC DRUGS NEWER ANTIEPILEPTIC DRUGS DR. PIYUSH OJHA DM RESIDENT DEPARTMENT OF NEUROLOGY GOVT MEDICAL COLLEGE, KOTA Ideal Properties for an Antiepileptic Drug…
ORIGINAL RESEARCH Open Access Omalizumab vs. placebo in the management of days (omalizumab 95.5% vs. placebo 89.2% p pi fr 4 n Carrillo et al. World Allergy Organization…
Slide 1 Antipsychotic agents By S.Bohlooli PhD School of Medicine, Ardabil University of Medical Sciences Slide 2 Dopamine neurons reduce activity. Postsynaptic D-2…
Slide 1 New Paradigms, New Treatments in Relapsed/Refractory Disease: An Update Kenneth C. Anderson, M.D. Jerome Lipper Multiple Myeloma Center Dana-Farber Cancer Institute…
Pharmacotherapy in Psychotic Disorders Antipsychotic drugs Treat the symptoms of the disorder Do not cure schizophrenia Include two major classes: Dopamine Receptor Antagonists…